aTyr Pharma, Inc. (LIFE)
(Delayed Data from NSDQ)
$0.62 USD
+0.01 (1.61%)
Updated May 3, 2019 04:00 PM ET
After-Market: $0.62 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For LIFE
-
Atyr Pharma: Q1 Earnings Snapshot
-
Atyr Pharma: Q4 Earnings Snapshot
-
Atyr Pharma: Q3 Earnings Snapshot
-
Atyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates
-
Atyr Pharma: Q2 Earnings Snapshot
-
Atyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates
-
Atyr Pharma: Q1 Earnings Snapshot
-
Atyr Pharma: Q4 Earnings Snapshot
-
Atyr Pharma (LIFE) Reports Q4 Loss, Tops Revenue Estimates
-
Atyr Pharma (LIFE) Reports Q3 Loss, Lags Revenue Estimates
-
Atyr Pharma: Q3 Earnings Snapshot
-
Atyr Pharma: Q2 Earnings Snapshot
-
Atyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates
-
Atyr Pharma (LIFE) Reports Q3 Loss, Misses Revenue Estimates
-
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Atyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates
-
Atyr Pharma (LIFE) Reports Q1 Loss, Lags Revenue Estimates
-
Analysts Estimate Atyr Pharma (LIFE) to Report a Decline in Earnings: What to Look Out for
-
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Atyr Pharma (LIFE) Reports Q2 Loss, Misses Revenue Estimates
-
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Atyr Pharma (LIFE) Q1 Earnings and Revenues Surpass Estimates
-
Atyr Pharma (LIFE) Reports Q4 Loss, Beats Revenue Estimates (Revised)
-
Atyr Pharma (LIFE) Reports Q4 Loss, Lags Revenue Estimates
-
TMO's Earnings Beat, LIFE Buyout on Track